Avicanna Inc. (TSX:AVCN) Email Format

Biotechnology ResearchOntario, Canada51-200 Employees

Avicanna Inc. is a Toronto, Ontario-based biotechnology company focused on the development and commercialisation of evidence-based cannabinoid products for medical and pharmaceutical use worldwide. Through its integrated R&D and clinical development platform, the company has brought more than 30 products to market across medical cannabis, wellness, and pharmaceutical indications. Its Medical Cannabis and Wellness offering, RHO Phyto, provides proprietary formulations delivered orally, sublingually, topically, and transdermally with varying cannabinoid ratios, and supports education for patients and medical communities. 
 
 Avicanna maintains a pharmaceutical pipeline of indication-specific, patent-pending drug candidates at various stages of development, with its first pharmaceutical preparation, Trunerox, approved in Colombia and pursuing registration in other South American markets. The company also operates MyMedi.ca Medical Cannabis Care, a platform run by Northern Green Canada Inc. that provides pharmacist-led patient support and education, including services for distinct patient groups and reimbursement collaborations. Recent activity includes hosting its 6th annual clinical symposium on Cannabinoid-based Therapeutics in Toronto in June 2026.

Sign up for free to view info

Company overview Employee directory